Flow Traders U.S. LLC acquired a new stake in shares of Phoenix Biotech Acquisition Corp. (NASDAQ:PBAXU – Get Rating) during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm acquired 11,483 shares of the company’s stock, valued at approximately $116,000.
Separately, Cubist Systematic Strategies LLC acquired a new stake in shares of Phoenix Biotech Acquisition during the second quarter worth approximately $235,000.
Phoenix Biotech Acquisition Price Performance
PBAXU stock opened at $10.47 on Friday. Phoenix Biotech Acquisition Corp. has a twelve month low of $9.87 and a twelve month high of $10.61. The firm has a 50 day simple moving average of $10.38 and a 200-day simple moving average of $10.25.
About Phoenix Biotech Acquisition
Phoenix Biotech Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It engages in identifying and acquiring a business that focuses on the healthcare or healthcare related industries in the United States and Europe.
See Also
- Get a free copy of the StockNews.com research report on Phoenix Biotech Acquisition (PBAXU)
- Fossil Group: Should You Bet On Consumer Discretionary In 2023?
- BJ’s Wholesale Club Stock Moves Higher After Strong Results
- Monthly Realty Income is About to Get Bigger
- 3 Large Cap Dividend Challengers for Millennial Investors
- Sea Ltd Is On The Verge Of A 100% Rally, Should You Buy?
Receive News & Ratings for Phoenix Biotech Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phoenix Biotech Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
